Add to ORKGThere is currently considerable interest in antibodies directed against phospholipids. Several clinical associations with these antibodies have been defined, the strongest ones being with thrombosis and recurrent foetal loss. These antibodies were originally studied in patients with systemic lupus erythematosus, but they have also been found to occur in patients who do not have this disease. This paper describes two such patients and discusses current views on antiphospholipid antibodies.peer-reviewe
The antiphospholipid syndrome is a systemic autoimmune disease defined by thrombotic or obstetrical ...
Antiphospholipid syndrome (APS) is an autoimmune disease characterised by thrombosis and pregnancy c...
The causes of thrombosis and pregnancy loss in anti phospholipid syndrome (APS) are still unknown, a...
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphosp...
The antiphospholipid antibodies (aPL), namely, the lupus anticoagulant and the anticardiolipin antib...
The antiphospholipid syndrome has been described for the first time by Graham Hughes in 1983 as a co...
The clinical spectrum of the anti-phospholipid syndrome (APS) is not limited to vascular thrombosis ...
Antiphospholipid syndrome is an autoimmune diseasecharacterized by antiphospholipid antibodies and a...
The antiphospholipid syndrome is defined as the association between the presence of antiphospholipid...
[Antiphospholipid antibodies mechanisms of action and clinical implications] Two groups of antiphosp...
Objective: The aim of the study is to perform a systematic review on the recent available evidence o...
The antiphospholipid antibodies included as laboratory criteria of the antiphospholipid syndrome (AP...
AbstractAntiphospholipid antibodies induce a prothrombotic state potentially causing arterial and ve...
AIMS: To review the historical reports on antiphospholipid antibodies (aPL) from the early years of ...
Antiphospholipid antibodies are commonly related to connective tissue disorders, the use of certain ...
The antiphospholipid syndrome is a systemic autoimmune disease defined by thrombotic or obstetrical ...
Antiphospholipid syndrome (APS) is an autoimmune disease characterised by thrombosis and pregnancy c...
The causes of thrombosis and pregnancy loss in anti phospholipid syndrome (APS) are still unknown, a...
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphosp...
The antiphospholipid antibodies (aPL), namely, the lupus anticoagulant and the anticardiolipin antib...
The antiphospholipid syndrome has been described for the first time by Graham Hughes in 1983 as a co...
The clinical spectrum of the anti-phospholipid syndrome (APS) is not limited to vascular thrombosis ...
Antiphospholipid syndrome is an autoimmune diseasecharacterized by antiphospholipid antibodies and a...
The antiphospholipid syndrome is defined as the association between the presence of antiphospholipid...
[Antiphospholipid antibodies mechanisms of action and clinical implications] Two groups of antiphosp...
Objective: The aim of the study is to perform a systematic review on the recent available evidence o...
The antiphospholipid antibodies included as laboratory criteria of the antiphospholipid syndrome (AP...
AbstractAntiphospholipid antibodies induce a prothrombotic state potentially causing arterial and ve...
AIMS: To review the historical reports on antiphospholipid antibodies (aPL) from the early years of ...
Antiphospholipid antibodies are commonly related to connective tissue disorders, the use of certain ...
The antiphospholipid syndrome is a systemic autoimmune disease defined by thrombotic or obstetrical ...
Antiphospholipid syndrome (APS) is an autoimmune disease characterised by thrombosis and pregnancy c...
The causes of thrombosis and pregnancy loss in anti phospholipid syndrome (APS) are still unknown, a...